Pulmonary innate immunity and pathogens of the order Actinomycetales
肺部先天免疫和放线菌目病原体
基本信息
- 批准号:8284436
- 负责人:
- 金额:$ 3.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-01 至 2012-12-31
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeActinomycetalesAirAlveolarAlveolar MacrophagesAlveolusAnatomyAntimicrobial EffectBacteriaBathingBindingBiologyBiomedical ResearchBreathingCarbohydratesCause of DeathCellsChemotaxisCommunicable DiseasesComplexCore FacilityDataDiseaseDisease OutcomeDoctor of PhilosophyEconomicsEligibility DeterminationEmploymentEnvironmentEpithelial CellsEquus caballusFacultyFosteringGasesGene ExpressionGenus MycobacteriumGrowthHistopathologyImmuneImmune responseImmune systemImmunocompromised HostImmunotherapyIndustryInfectionInflammationInositolInvestigationK-Series Research Career ProgramsLaboratoriesLicensingLifeLiquid substanceLungLung diseasesMannoseMediatingMedicineMentorsModelingModificationMorbidity - disease rateMusMutationMycobacterium smegmatisMycobacterium tuberculosisNatural ImmunityOhioOpportunistic InfectionsOrganOutcomeParticulate MatterPathogenesisPathologyPatientsPatternPhagocytosisPhospholipidsPopulationPositioning AttributePrevalencePrincipal InvestigatorProductionPropertyProteinsPulmonary Surfactant-Associated Protein APulmonary Surfactant-Associated Protein DPulmonary alveolar structureResearchResearch PersonnelResearch ProposalsResistanceRespiratory Tract InfectionsRhodococcusRhodococcus equiScientistSourceStudentsSurfaceSurface TensionTestingTissuesTrainingTraining ProgramsTraining SupportTuberculosisUniversitiesVeterinariansVeterinary MedicineVirulenceVirulentWorld Healthaerosolizedbactericidecell envelopecollegecytokineexperiencein vitro Assayin vivoinsightlipoarabinomannanmacrophagemicrobialmigrationmonocyteneutrophilnovel strategiespathogenpreventpublic health relevancereceptorrespiratoryresponsestatisticssurfactant
项目摘要
DESCRIPTION (provided by applicant): THE CANDIDATE: Dr. Tracy Carlson, a licensed veterinarian with board-eligibility in veterinary anatomic pathology, is completing a Ph.D. training program at the Ohio State University (OSU). The K01 SERCA will support her training and progression to scientific independence. THE ENVIRONMENT: OSU has an extensive biomedical research complex including state of the art core facilities in the Colleges of Medicine / Veterinary Medicine. Dr. Larry Schlesinger, the Principal Investigator's mentor, is the Director of both the Infectious Disease Division and the Center for Microbial Interface Biology. Dr. Schlesinger is an experienced mentor in the training of Ph.D. students and K award trainees. THE TRAINING PLAN: The first year of the K award will be used to support the completion of the Ph.D. training of Dr. Carlson in a mentored environment in Dr. Schlesinger's laboratory. The last four years will be used to facilitate Dr. Carlson's transition to an independent researcher following the plan outlined in the research proposal. This will foster eligibility for employment in competitive staff and faculty scientist positions. THE RESEARCH: The initial interaction of respiratory pathogens with the innate immune system is critical for determining the outcome of disease particularly for bacteria of the order Actinomycetales, such as Mycobacteria and Rhodococcus spp., which have the ability to live in innate immune cells (alveolar macrophages). Interaction of the local lung environment, in particular surfactant protein D, has antimicrobial effects on Mycobacterium tuberculosis in in vitro assays. In this research proposal we will further define the interaction of SP-D with M. tuberculosis and the effect it has on the survival of the bacteria in in vitro assays and in vivo in part by exploring the effect of SP-D mutations on the outcome of infection. Additional research will focus on the pulmonary host response to the related Rhodococcus equi, a bacterium that is a significant source of opportunistic pulmonary disease in immunocompromised (AIDS) patients as well as being an important cause of economic loss and morbidity as a disease of young horses. Defining and modulating the interaction of the pulmonary environment with these pathogens will open new avenues of investigation into potential targeted immunotherapies.
PUBLIC HEALTH RELEVANCE: Tuberculosis is one of the leading causes of death due to a single infectious disease agent and infects ~ 1/3 of the world's population. The related Rhodococcus equi is an opportunistic infection in AIDS patients and a cause of economic loss / morbidity in the equine industry. Our project will define the initial interaction of these bacteria with the lung innate immune system and generate novel approaches to immunotherapy.
描述(由申请人提供):候选人:特雷西·卡尔森(Tracy Carlson)博士是一名有执照的兽医,董事会有资格获得兽医解剖病理学,正在填写博士学位。俄亥俄州立大学(OSU)的培训计划。 K01 SERCA将支持她的训练和发展至科学独立性。环境:OSU拥有广泛的生物医学研究综合体,包括医学 /兽医学院中最先进的核心设施。主要研究者的导师Larry Schlesinger博士是传染病部和微生物界面生物学中心的主任。 Schlesinger博士是培训博士学位的经验丰富的导师。学生和K奖学员。培训计划:K奖的第一年将用于支持博士学位的完成。在施莱辛格博士实验室的指导环境中,对卡尔森博士的培训。在研究建议中概述的计划之后,过去四年将用于促进卡尔森博士向独立研究人员的过渡。这将培养有资格在有竞争力的员工和教师科学家职位上就业。研究:呼吸道病原体与先天免疫系统的初始相互作用对于确定疾病的结局至关重要,特别是对于诸如分枝杆菌和杜鹃花spp的细菌的细菌,它们具有生活在先天免疫细胞中的能力(肺泡巨摩托杆)。局部肺部环境的相互作用,特别是表面活性剂蛋白D,在体外测定中对结核分枝杆菌具有抗菌作用。在这项研究建议中,我们将进一步定义SP-D与结核分枝杆菌的相互作用及其对细菌在体外测定和体内生存的影响,部分原因部分是通过探索SP-D突变对感染结果的影响。进一步的研究将集中于对相关犀牛Equi的肺部宿主反应,这是一种细菌,是免疫强化(AIDS)患者的机会性肺疾病的重要来源,也是造成经济损失和发病率作为幼马疾病的重要原因。定义和调节肺部环境与这些病原体的相互作用将为潜在的靶向免疫疗法开放新的研究途径。
公共卫生相关性:结核病是由于单一传染病毒剂而导致的主要死亡原因之一,并感染了世界人群的约1/3。相关的Rhodococcus Equi是艾滋病患者的机会感染,是马产业的经济损失 /发病率的原因。我们的项目将定义这些细菌与肺部免疫系统的初始相互作用,并生成新颖的免疫疗法方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TRACY K CARLSON其他文献
TRACY K CARLSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TRACY K CARLSON', 18)}}的其他基金
Pulmonary innate immunity and pathogens of the order Actinomycetales
肺部先天免疫和放线菌目的病原体
- 批准号:
7787847 - 财政年份:2010
- 资助金额:
$ 3.41万 - 项目类别:
Pulmonary innate immunity and pathogens of the order Actinomycetales
肺部先天免疫和放线菌目的病原体
- 批准号:
8092783 - 财政年份:2010
- 资助金额:
$ 3.41万 - 项目类别:
相似国自然基金
基于“活性-代谢组-基因组-SMART”整合策略发掘老鼠簕内生放线菌新型先导化合物
- 批准号:82360696
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
AUF-LC-MS+Blocker技术导向的海洋放线菌中PTP1B变构抑制剂的挖掘及其改善胰岛素抵抗作用研究
- 批准号:82304349
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
放线菌新型萜类天然产物的基因组挖掘和生物合成研究
- 批准号:82304325
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
杨树次生代谢通路协同根际放线菌调控抗病性研究
- 批准号:32371906
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于原位培养及分子网络技术的贵州洞穴极端环境uncultured放线菌资源及其次级代谢潜力深度挖掘
- 批准号:32360004
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Pulmonary innate immunity and pathogens of the order Actinomycetales
肺部先天免疫和放线菌目的病原体
- 批准号:
7787847 - 财政年份:2010
- 资助金额:
$ 3.41万 - 项目类别:
Pulmonary innate immunity and pathogens of the order Actinomycetales
肺部先天免疫和放线菌目的病原体
- 批准号:
8092783 - 财政年份:2010
- 资助金额:
$ 3.41万 - 项目类别:
EPIDEMIOLOGY OF INFECTION BY NONTUBERCULOUS MYCOBACTERIA
非结核分枝杆菌感染的流行病学
- 批准号:
3444924 - 财政年份:1987
- 资助金额:
$ 3.41万 - 项目类别:
EPIDEMIOLOGY OF INFECTION BY NONTUBERCULOUS MYCOBACTERIA
非结核分枝杆菌感染的流行病学
- 批准号:
3565493 - 财政年份:1987
- 资助金额:
$ 3.41万 - 项目类别:
EPIDEMIOLOGY OF INFECTION BY NONTUBERCULOUS MYCOBACTERIA
非结核分枝杆菌感染的流行病学
- 批准号:
3444925 - 财政年份:1987
- 资助金额:
$ 3.41万 - 项目类别: